The US Southern Border is a top issue for voters and a potential liability for President Biden. Today, Biden is expected to issue an order that could limit the flow of people across the border, could this also limit the political fallout for him. On for more than six weeks and appears Prime Minister Modi has won another five years in power.
And people suffering from post-traumatic stress disorder don't have many treatment options to turn to. Today, the FDA will review whether an illegal party drug could provide relief. If not MDMA, there really is nothing else out there in the pipeline. Stay with us. We've got the news you need to start your day. The following message comes from NPR sponsor Satfa. Founder and CEO Ron Rudson is proud that each Satfa mattress is made to order.
Your mattress has a birth date after you order it. Nothing sits in muggy warehouses. Nothing sits in muggy basements of stores. When you order it, you're getting your product made fresh for you and people love that. To learn more go to swa.com slash NPR.
This message comes from NPR sponsor the Capital One Venture X Card. Earn unlimited two X miles on everything you buy. Plus get access to a $300 annual credit for bookings through Capital One Travel. What's in your wallet? Terms apply. Details at CapitalOne.com. This message comes from NPR sponsor BetterHelp. When life is flying by, it's important to take a moment to hit pause, set intentions, and reset. That's where BetterHelp Online therapy comes in.
Just fill out a brief questionnaire to get matched with a licensed therapist and switch therapists any time for no additional charge. Visit BetterHelp.com slash NPR. The large number of asylum seekers at the Southern border has become a political headache for President Biden in this election year. A few months ago, a bipartisan group of senators worked with the White House to negotiate a compromise that would have addressed this issue, but Republicans walked away from the deal.
So today, President Biden is expected to announce actions he will take through executive order and he has invited several mayors of border cities to join him at the White House. NPR immigration correspondent, Sarah Heel Martinez-Biltron is joining us this morning to tell us more about this. Good morning, Sarah Heel. Good morning. Do we have any details yet? Has the White House said anything publicly?
So we don't know much about it yet, but we do know that ever since the Senate failed to pass a measure, the White House has said it would consider taking executive action. And Michelle, the Biden administration has been peace-meeting restrictions for the last few weeks. For example, he recently announced a new rule intended to speed up the removal of some migrants who are not eligible for asylum.
And what Biden is expected to announce today would also limit asylum claims. The expectation is that Biden will invoke and rely on and there with me here because it's going to sound clunky. Section 212F of the Immigration and Naturalization Act. I talked to Lily Axelrod, who is an immigration attorney based in Memphis, Tennessee. And here's how she described it.
So Section 212F is a fairly broad provision that grants the President's authority to restrict immigration and visitors, non-immigrant visitors from coming into the United States when he thinks or she thinks that they're detrimental to the interests of the United States. In the past, this section has been used on the grounds of national security. The provision would also allow the President to suspend entries once the number of unauthorized crossings reaches a certain daily threshold.
And this could be the most impactful border management policy to come out of this administration so far. But it's widely expected that it will face court challenges. I got it. Okay, so can you tell us how the southern border looks in terms of unauthorized crossings at the moment?
I mean, it's way different than how it looked last year. Back then, we saw a record number of unauthorized crossings and many of these migrants were seeking asylum. But those numbers have plummeted this year. And the reason for that, according to immigration policy analysts, is Mexico. Mexico has been cracking down on illegal migration at the origin of the US.
But at the same time, we know that border communities have been challenged by this influx of migrants going back. What is it? He's sort of some years now. You've been talking to mayors of these cities. What are they saying? Well, I reached out to a bunch of border mayors and some of them have been invited to today's announcement at the White House. El Paso Mayor Oscar Liser will be there. He told me in a statement that his city is a welcoming place, but that no community can continue.
The resource is expended on this humanitarian crisis. So he says he's looking forward to hearing from Biden. We know that the mayors of San Diego, California and Yuma, Arizona were also invited. And then Michelle, there are some mayors who say they were not invited, like the mayor of E.O. Pass, Texas, a community that saw some of the highest number of unauthorized migrants last year.
Mayor Rolando Salinas told me he wishes this policy rollout had been done back in December when he city saw about 2000 to 3000 migrants per day. He says quote, we won't forget those days. Sergio Martinez-Biltrán is an immigration correspondent. Sergio, thank you. You're welcome. After six marathon weeks of voting across India, where nearly one billion people were eligible to vote to cast a ballot or press buttons on an electronic voting machine counting is now underway to tally their results.
The initial result suggests that the prime minister Narendra Modi of the BJP party will become prime minister for the third time. On the line with us now to tell us more is NPR's D.A. Hadid. She's in the Capitol, New Delhi. Hello, D.A. Hi, Michelle. How are the numbers looking so far? Well, so far, tally by India's Election Commission indicates that Modi's party, it's called the BJP, has won the largest number of seats in parliament.
It hasn't won a clear majority, but with its allies, it looks like it will be able to form a coalition government. On the flip side, India's opposition alliance has done better than exit polls expected, but it hasn't won enough seats to form government according to the council far. So essentially, it's a victory for the BJP and a victory for the prime minister. Yet again. Yes, but you know, I'm on the ground in the Capitol, New Delhi.
And if you were here just judging by the mood outside each of the campaign headquarters, you would say that Modi's BJP had lost in the opposition one. And that's because at the outset of these elections, Modi promised that his party would win a super majority. The exit polls predicted Modi's party would nearly hit those numbers. And so outside the BJP headquarters, we saw a man seemingly prey to a Modi like God, besieging him to come back to power.
And so unless there's a dramatic change as counting continues, yes, Modi will return to power. He will be the only prime minister after the founder of modern India, Jawaharlal Nehru, to win three times. But he'll rule as a part of a coalition, not as this seemingly unstoppable juggernaut led by a man who recently suggested to a journalist that he was chosen by God.
So, dear, what does this mean for India going forward? Well, Michelle, I think it will be harder for Modi and his party to continue their vast recasting of India as a country that elevates its Hindu majority above other citizens. Harder but not impossible. It also appears to have signaled to the opposition, which is led by the Congress party that power is within reach.
That party is led by Rahul Gandhi, the great grandson of India's first prime minister. It used to dominate Indian politics. But it's waned in recent years and under Rahul's leadership, the party shrank and shrank. But in these elections, the party looks like it won double the seats that it did in the previous ones. So, now Rahul can show voters that he and the Congress party can fight back.
There'll be a more muscular opposition. And critics say that will also likely shake Indian institutions, which critics say were increasingly partial to Modi and his party in recent years, like the mainstream media, YouTube news outlets, influences law enforcement agencies, and even India's election commission itself. That is NPR's D.A. Hadid in New Delhi. D.A. Thank you so much. Thank you, Michelle.
MDMA is what we're going to talk about now. That's a party drug. It's usually associated with all night raves. But when company is seeking FDA approval to use it as a mainstream treatment in mental health care. Yeah, today a panel of experts to the Food and Drug Administration will review the evidence behind using MDMA to treat post-traumatic stress disorder, what they say could affect whether the agency approves the treatment.
NPR's Will Stone is whether it's not to tell us more about this. Good morning. Good morning. So this treatment is called MDMA assisted therapy. How does it work? Well, it basically combines a form of talk therapy with the psychedelic drug MDMA. So a patient with PTSD gets a dose and then works through their trauma with two therapists.
The clinical trial involved several of these dosing sessions. FDA staff have said based on that data, participants appear to experience quote rapid clinically meaningful durable improvement in their PTSD symptoms. I asked Dr. Mason Marx about the chances of approval for MDMA. He studies psychedelics at Harvard and Florida State University.
At first glance, data looks promising. There are also legitimate questions, but just looking at the totality of the circumstances. I suspect it will be approved. In fact, the drug company that's funded this research called Lycos therapeutics has raised more than a hundred million dollars ahead of possible FDA approval.
So Dr. Marx referred to legitimate questions. What are those questions? That's right. This is not a done deal because there are questions about whether the findings from the trials are solid. And one big concern is that most people in the trials could tell whether they received MDMA or a placebo ideally in clinical trials. People can't tell.
Obviously, that's hard to do with psychedelics, but ultimately when this does happen, it can lead to bias and that skews the results. There are other concerns about the methods and long-term data, but what's caught attention more recently are inflammatory allegations about the trials. Okay, so what are those? Essentially, there are claims that some therapists and investigators may have pushed patients to report good results and overlooked adverse events.
That was emphasized in a recent report from the Institute for Clinical and Economic Review. This is an independent group that did a deep dive into the data and said there were substantial concerns about the validity of the results. Some of that is based on what trial participants have said. Sarah McNamy was in one of the trials. Take a listen to part of her public testimony read by a friend.
Three months after I was given my first dose of MDMA, I was for a time one of the staunchest advocates for MDMA therapy. The problem is that I was also suicidal and clinically decompensating in drastic and unprecedented ways. And what she means by that is basically she was having worsening symptoms. And MacDamey says her therapist played up the idea that she was helping make history.
And she says others in the trials have also shared with her negative experiences that did not get fully captured in the published findings. As it turns out, there was a petition calling for this FDA public meeting in part because of these kind of concerns. So what could this mean for possible approval of the treatment?
The drug maker, Lycos has pushed back on these allegations and said they stand by their results, therapists in the trials, have also said this outside report was based on hearsay and misrepresentations. And there are certainly many who do feel MDMA should be approved, including groups representing military veterans. Here's former Army Ranger Jesse Gould with the nonprofit called Heroic Hearts Project.
If not MDMA, there really is nothing else out there in the pipeline. So yes, there may be flaws in the study, but what is the risk reward of potentially saving millions of lives? So this panel of advisors will have to weigh all of this because the FDA wants to make a decision by early August. That is NPR's Will Stone. Will thank you. Thank you. And that's up first for Tuesday June 4th. I'm Michelle Martin.
And I mean Martinez, listen to Consider This from NPR. The Pentagon is trying to cut healthcare costs by outsourcing service members care to the private sector. What could that mean for the future of Battlefield Medicine? Find out on Consider This. This episode of First West edited by Alfredo Carbohal, John Hilton, Jane Greenhall, Ali Schweitzer and Alice Wolfley.
It was produced by Z.N. Butch, Ben Abrams and Milton Gerrata, our technical director is Zach Coleman and we get engineering support from Arthur Laurent. Join us again tomorrow. A former president found guilty while running for re-election. For a story, this big, one podcast is not enough. Here at NPR, we've got you covered from every angle. You can get the news as it happens and legal analysis on the podcast Trump's Trials.
For all the latest on what it means for the 2024 election, head on over to the NPR Politics Podcast. Find Trump's Trials and the NPR Politics Podcast, wherever you get your podcasts. This message comes from NPR Sponsor Mint Mobile. From the gas pump to the grocery store, inflation is everywhere. So Mint Mobile is offering premium wireless starting at just $15 a month. To get your new phone plan for just $15, go to MintMobile.com-switch.
This message comes from NPR Sponsor HubSpot. Imagine growing a business with high quality leads, fast closing deals, wildly happy customers, and more benchmark breaking quarters. It's not a miracle. It's HubSpot. Visit HubSpot.com to get started today.